iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$4.73M
Expense Ratio	0.47%
PE Ratio	16.48
Shares Out	150,000
Dividend (ttm)	$0.32
Dividend Yield	1.03%
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Annual
Payout Ratio	16.24%

Volume	5,303
Open	31.71
Previous Close	31.55
Day's Range	31.00 - 31.71
52-Week Low	17.86
52-Week High	37.00
Beta	0.73
Holdings	68
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

42.12% of assets

Name	Symbol	Weight
Xenon Pharmaceuticals Inc.	XENE	5.40%
Praxis Precision Medicines, Inc.	PRAX	5.14%
Axsome Therapeutics, Inc.	AXSM	4.34%
Biogen Inc.	BIIB	4.28%
Alkermes plc	ALKS	3.93%
Dianthus Therapeutics, Inc.	DNTH	3.92%
Scholar Rock Holding Corporation	SRRK	3.90%
Supernus Pharmaceuticals, Inc.	SUPN	3.82%
Denali Therapeutics Inc.	DNLI	3.75%
Centessa Pharmaceuticals plc	CNTA	3.63%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.31981	Dec 19, 2025
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Performance

IBRN had a total return of 32.39% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.35%.